BridgeMD
New treatment option for Composite Resins
Official title Color Adjusting Resin Composite in Anterior Tooth Restorations: Clinical and Subjective Evaluations
ClinicalTrials.gov ID: NCT06884787
What this study is testing
What is Conventional nanohybrid multishade composite?
Conventional nanohybrid multishade composite is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for composite resins.
Also referred to as Conventional resin based composite (RBC).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The ability of single-shade composite restorations to blend with adjacent tooth structure shades is called chameleon effect. This effect is enhanced using specially designed spherical particles in the composite material which will help diffuse light in a way that mimics the natural color and translucency of teeth making the restoration nearly imperceptible to the naked eye.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Patients attending the dental clinics at JUST in Irbid or on the university campus.
- Patients aged 18 years and older.
- Patients with good oral hygiene.
- Patients with a positive attitude towards dental treatment.
- Patients require restorations on at least two anterior teeth.
You likely can't join if
- Teeth with enamel or dentin deformations.
- Teeth affected by fluorosis or tetracycline staining.
- Teeth with severe discoloration.
- Primary teeth.
- Patients with gingival inflammation or periodontal disease.
- Patients undergoing active orthodontic treatment.
See the full eligibility criteria
- Patients attending the dental clinics at JUST in Irbid or on the university campus.
- Patients aged 18 years and older.
- Patients with good oral hygiene.
- Patients with a positive attitude towards dental treatment.
- Patients require restorations on at least two anterior teeth.
- Patients with spaces between teeth that do not require orthodontic treatment for correction.
- Patients with healthy pulp or reversible pulpitis.
- Patients without any periapical lesions
- Teeth with enamel or dentin deformations.
- Teeth affected by fluorosis or tetracycline staining.
- Teeth with severe discoloration.
- Primary teeth.
- Patients with gingival inflammation or periodontal disease.
- Patients undergoing active orthodontic treatment.
- Heavy smokers.
- Very deep or very shallow cavities.
- Class IV cavities where more than half of the tooth surface is lost.
- Traumatic Class IV cavities with pulp exposure.
- Class III cavities that do not open labially.
The study team makes the final eligibility decision.
Where it's taking place
- Irbid, Jordan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Irbid, Jordan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.